Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-014006

Chief Operating Officer sold 10,365 shares at an average $50.74 ($525,939)

  • Chief Operating Officer acquired 10,365 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Goldshleger Ilya Chief Operating Officer 2024-02-09 Option exercise 10b5-1 +5,365 $18.90 $101,399 31,840 D
Goldshleger Ilya Chief Operating Officer 2024-02-09 Option exercise 10b5-1 +5,000 $23.04 $115,200 36,840 D
Goldshleger Ilya Chief Operating Officer 2024-02-09 Sale 10b5-1 −5,365 $50.50 $270,939 31,475 D
Goldshleger Ilya Chief Operating Officer 2024-02-09 Sale 10b5-1 −5,000 $51.00 $255,000 26,475 D
Derivatives
Goldshleger Ilya Chief Operating Officer 2024-02-09 Option exercise · Stock Option (right to buy) 10b5-1 −5,365 3,995 D
Goldshleger Ilya Chief Operating Officer 2024-02-09 Option exercise · Stock Option (right to buy) 10b5-1 −5,000 25,000 D
Open-market sales · 10,365 sh · avg $50.74 · $525,939
Loading xslF345X05/ownership.xml…